Cemi schrieb am 16.12.2020 14:17:
DonJohn schrieb am 16.12.2020 14:03:
In November 2020 a meta-analysis found only weak evidence of benefit.
Welche Meta-Analyse? Wo ist die Quelle?
https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31457
Ich hab da mal reingeschaut und zitiere:
"... the random effect model revealed that adding ivermectin led to significant clinical improvement compared to usual therapy (OR=1.98, 95% CI: 1.11 to 3.53, P=0.02). However, this should be inferred cautiously as the quality of evidence is very low. Currently, many clinical trials are on-going, and definitive evidence for repurposing this drug for COVID-19 patients will emerge only in the future."
Das klingt doch schon mal vielversprechend ;)